Prognostic values of VEGF and IL-8 in malignant pleural effusion in patients with lung cancer

References

• An SJ, Huang YS, Chen ZH, et al. (2012). Posttreatment plasma VEGF levels may be associated with the overall survival of patients with advanced non-small cell lung cancer treated with bevacizumab plus chemotherapy. Med Oncol 29:627–32
   PubMed Web of Science ®Google Scholar
• Ceyhan BB, Ozgun S, Celikel T, et al. (1996). IL-8 in pleural effusion. Respir Med 90:215–21
   PubMed Web of Science ®Google Scholar
• Cheng D, Liang B, Li YH. (2012). Application of MMP-7 and MMP-10 in assisting the diagnosis of malignant pleural effusion. Asian Pac J Cancer Prev 13:505–9
   PubMed Web of Science ®Google Scholar
• Chien CY, Su CY, Hwang CF, et al. (2006). High expressions of CD105 and VEGF in early oral cancer predict potential cervical metastasis. J Surg Oncol 94:413–17
   Google Scholar
• Economidou F, Antoniou KM, Soufla G, et al. (2010). Role of VEGF-stromal cell-derived factor-1alpha/CXCL12 axis in pleural effusion of lung cancer. J Recept Signal Transduct Res 30:154–60
   PubMed Web of Science ®Google Scholar
• Froudarakis ME. (2012). Pleural effusion in lung cancer: more questions than answers. Respiration 83:367–76
   PubMed Web of Science ®Google Scholar
• Heffner JE, Klein JS. (2008). Recent advances in the diagnosis and management of malignant pleural effusions. Mayo Clin Proc 83:235–50
   Google Scholar
• Johnston WW. (1985). The malignant pleural effusion. A review of cytopathologic diagnoses of 584 specimens from 472 consecutive patients. Cancer 56:905–9
   PubMed Web of Science ®Google Scholar
• Kraft A, Weindel K, Ochs A, et al. (1999). Vascular endothelial growth factor in the sera and effusions of patients with malignant and nonmalignant disease. Cancer 85:178–87
   PubMed Web of Science ®Google Scholar
• Li X, Wan L, Shen H, et al. (2012). Thyroid transcription factor-1 amplification and expressions in lung adenocarcinoma tissues and pleural effusions predict patient survival and prognosis. J Thorac Oncol 7:76–84
   Google Scholar
• Lurje G, Zhang W, Schultheis AM, et al. (2008). Polymorphisms in VEGF and IL-8 predict tumor recurrence in stage III colon cancer. Ann Oncol 19:1734–41
   PubMed Web of Science ®Google Scholar
• Masood R, Cai J, Zheng T, et al. (2001). Vascular endothelial growth factor (VEGF) is an autocrine growth factor for VEGF receptor-positive human tumors. Blood 98:1904–13
   PubMed Web of Science ®Google Scholar
• Moche M, Hui DS, Huse K, et al. (2005). [Matrix metalloproteinases and their inhibitors in lung cancer with malignant pleural effusion]. Pneumologie 59:523–8
   Google Scholar
• Mohammed KA, Nasreen N, Hardwick J, et al. (2003). Mycobacteria induces pleural mesothelial permeability by down-regulating beta-catenin expression. Lung 181:57–66
   PubMedGoogle Scholar
• Ning Y, Manegold PC, Hong YK, et al. (2011). Interleukin-8 is associated with proliferation, migration, angiogenesis and chemosensitivity in vitro and in vivo in colon cancer cell line models. Int J Cancer 128:2038–49
   PubMed Web of Science ®Google Scholar
• Qian Q, Sun WK, Zhan P, et al. (2012a). Role of monocyte chemoattractant protein-1, tumor necrosis factor-alpha and interleukin-6 in the control of malignant pleural effusion and survival in patients with primary lung adenocarcinoma. Int J Biol Markers 27:e118–24
   Google Scholar
• Qian Q, Zhan P, Sun WK, et al. (2012b). Vascular endothelial growth factor and soluble intercellular adhesion molecule-1 in lung adenocarcinoma with malignant pleural effusion: correlations with patient survival and pleural effusion control. Neoplasma 59:433–9
   PubMed Web of Science ®Google Scholar
• Roberts ME, Neville E, Berrisford RG, et al. (2010). Management of a malignant pleural effusion: British Thoracic Society Pleural Disease Guideline 2010. Thorax 65:ii32–40
   PubMed Web of Science ®Google Scholar
• Saponaro C, Malfettone A, Ranieri G, et al. (2013). VEGF, HIF-1alpha expression and MVD as an angiogenic network in familial breast cancer. PLoS One 8:e53070
   Google Scholar
• Shen YC, Liu MQ, Wan C, et al. (2012). Diagnostic accuracy of vascular endothelial growth factor for malignant pleural effusion: a meta-analysis. Exp Ther Med 3:1072–6
   PubMed Web of Science ®Google Scholar
• Sobin LH, Gospodarowicz MK, Wittekind C, et al. (2010). TNM classification of malignant tumours. Hoboken (NJ): Wiley-Blackwell
   Google Scholar
• Stieler K, Schumacher U, Horst AK, Fischer N. (2012). XMRV induces cell migration, cytokine expression and tumor angiogenesis: are 22Rv1 cells a suitable prostate cancer model? PLoS One 7:e42321
   PubMed Web of Science ®Google Scholar
• Strieter RM, Burdick MD, Mestas J, et al. (2006). Cancer CXC chemokine networks and tumour angiogenesis. Eur J Cancer 42:768–78
   PubMed Web of Science ®Google Scholar
• Tas F, Duranyildiz D, Oguz H, et al. (2006). Serum vascular endothelial growth factor (VEGF) and interleukin-8 (IL-8) levels in small cell lung cancer. Cancer Invest 24:492–6
   PubMed Web of Science ®Google Scholar
• Taubert J. (2001). Management of malignant pleural effusion. Nurs Clin North Am 36:665–83, vi
   Google Scholar
• Vysotskii MM, Digaeva MA, Kushlinskii NE, et al. (2009). Serum sFas, leptin, and VEGF in patients with ovarian cancer and benign tumors. Bull Exp Biol Med 148:810–14
   Google Scholar
• Wu Y, Jin M, Xu H, et al. (2010). Clinicopathologic significance of HIF-1alpha, CXCR4, and VEGF expression in colon cancer. Clin Dev Immunol. Epub 2010 Oct 7
   Google Scholar
• Xie K. (2001). Interleukin-8 and human cancer biology. Cytokine Growth Factor Rev 12:375–91
   PubMed Web of Science ®Google Scholar
• Yamaguchi T, Kimura H, Yokota S, et al. (2000). Effect of IL-6 elevation in malignant pleural effusion on hyperfibrinogenemia in lung cancer patients. Jpn J Clin Oncol 30:53–8
   Google Scholar
• Yang J, Wu HF, Qian LX, et al. (2006). Increased expressions of vascular endothelial growth factor (VEGF), VEGF-C and VEGF receptor-3 in prostate cancer tissue are associated with tumor progression. Asian J Androl 8:169–75
   Google Scholar
• Ye ZJ, Zhou Q, Yin W, et al. (2012). Interleukin 22-producing CD4 + T cells in malignant pleural effusion. Cancer Lett 326:23–32
   PubMed Web of Science ®Google Scholar
• Yuan A, Yang PC, Yu CJ, et al. (2000). Interleukin-8 messenger ribonucleic acid expression correlates with tumor progression, tumor angiogenesis, patient survival, and timing of relapse in non-small-cell lung cancer. Am J Respir Crit Care Med 162:1957–63
   PubMed Web of Science ®Google Scholar
• Zhang JX, Xie CM, Zhu ZW, et al. (2012). Potential role of AQP1 and VEGF in the development of malignant pleural effusion in mice. Med Oncol 29:656–62
   Google Scholar